Use of Thiazolidinediones and Risk of Bladder Cancer: Disease or Drugs?

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|8|5|364-370

ISSN： 1574-8863

Source： Current Drug Safety, Vol.8, Iss.5, 2013-11, pp. : 364-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of antihypertensive drugs and risk of skin cancer

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1545-1554

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease

By Pasternak Björn   Svanström Henrik   Schmiegelow Kjeld   Jess Tine   Hviid Anders  

American Journal of Epidemiology, Vol. 177, Iss. 11, 2013-06 ,pp. : 1296-1305

Oxford University Press

Access to resources Recommend Favorite

Predicting risk of bladder cancer in the UK

By Coupland Carol   Hippisley-Cox Julia  

British Journal of General Practice, Vol. 62, Iss. 604, 2012-11 ,pp. : 570-571

Royal College of General Practitioners

Access to resources Recommend Favorite

Genetic susceptibility to bladder cancer risk and outcome

By Gu Jian   Wu Xifeng  

Personalized Medicine, Vol. 8, Iss. 3, 2011-05 ,pp. : 365-374

Future Medicine

Access to resources Recommend Favorite

A Meta-Analysis of Tea Consumption and the Risk of Bladder Cancer

By  

Urologia Internationalis, Vol. 90, Iss. 1, 2012-10 ,pp. : 10-16

Karger

Access to resources Recommend Favorite